TNF and inflammatory bowel disease: In order to demonstrate the quantitative effects of anti-TNF therapy on the formation of SARS-CoV-2-specific antibodies, the antibody levels in IBD patients and in the control group were compared in the respective test procedures after the first and second vaccinations.